In this observational case-control study, considering the role of FGF21 and mitochondria in NAFLD pathogenesis, our first aim was to assess FGF21 expression and mtDNA-CN in Iranian NAFLD patients in different stages of the disease and compare those to healthy control group. Here, FGF21 is linked to metabolic dysfunction-associated steatotic liver disease.